Comparison of EPBD and EPBD combined with SEST in treatment of large choledocholithiasis
10.3969/j.issn.1007-1989.2017.06.017
- VernacularTitle:内镜下柱状气囊扩张术与内镜下柱状气囊扩张术联合乳头括约肌小切开治疗胆总管大结石的比较研究
- Author:
Lisheng TAO
;
Yaping XU
;
Jun YAO
- Keywords:
endoscopic retrograde cholangiopancreatography;
endoscopic papillary balloon dilation;
EPBD;
small endoscopic sphincterotomy;
SEST
- From:
China Journal of Endoscopy
2017;23(6):82-86
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the clinical efficacy and safety of endoscopic papillary balloon dilation (EPBD) and endoscopic papillary balloon dilation (EPBD) combined with small endoscopic sphincterotomy (SEST) in treatment of large choledocholithiasis. Methods 78 patients with large choledocholithiasis from January 2014 to December 2015 were randomly divided into EPBD group, and combination treatment group. The level of bilirubin, transaminase, alkaline phosphatase (ALP) before and after the operation, the success rates of stone removal, serum amylase of 24 h after the operation, the operation times of endoscopic retrograde cholangiopancreatography (ERCP) and whether complicated with postoperative pancreatitis were compared between the two groups. Results There was no significant difference of the success rates of stone removal, serum amylase of 24 h after the operation, the operation times of ERCP between the two groups. The level of bilirubin, transaminase, alkaline phosphatase (ALP) was declined after EPBD or EPBD and SEST, and the results of the two groups had no statistical significance (P > 0.05). Also there was no significant difference of the incidence of postoperative pancreatitis, postoperative bleeding and postoperative hyperamylasemia between the two groups (P > 0.05). Conclusion EPBD is worthy of promoting because it has a similar clinical efficacy and safety to EPBD and SEST in treatment of large choledocholithiasis.
